Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Clear all

239 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20033
20042
20053
20063
20073
20086
200911
20106
20118
20123
20137
201410
20157
201614
201716
201812
201920
202010
202110
202218
202316
202410
202513
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Unknown status47
Recruiting43
Terminated35
Withdrawn16
Active, not recruiting12
Not yet recruiting10
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Bristol-Myers Squibb4
M.D. Anderson Cancer Center4
Eisai Inc.3
Fuda Cancer Hospital, Guangzhou3
Incyte Biosciences International Sàrl3
Jonsson Comprehensive Cancer Center3
Peking Union Medical College Hospital3
Shanghai GeneChem Co., Ltd.3
Akeso2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular239
Liver Neoplasms44
Carcinoma, Non-Small-Cell Lung29
Colorectal Neoplasms28
Stomach Neoplasms24
Melanoma23
Carcinoma, Renal Cell22
Neoplasms18
Ovarian Neoplasms16
Neoplasm Metastasis15

Trials

Showing 76 to 100 of 239. Each trial links to its page on Pharma Observatory.

139 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.